342 related articles for article (PubMed ID: 10924321)
21. Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy.
Murakawa Y; Zhang W; Pierson CR; Brismar T; Ostenson CG; Efendic S; Sima AA
Diabetes Metab Res Rev; 2002; 18(6):473-83. PubMed ID: 12469361
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of prenyl pyrophosphates on the phosphatase activity of phosphotyrosyl protein phosphatase.
Chen HC; Chen CH; Chuang NN
J Exp Zool A Comp Exp Biol; 2004 Apr; 301(4):307-16. PubMed ID: 15039989
[TBL] [Abstract][Full Text] [Related]
23. Effects of hyperbaric exposure with high oxygen concentration on glucose and insulin levels and skeletal muscle-fiber properties in diabetic rats.
Yasuda K; Adachi T; Gu N; Matsumoto A; Matsunaga T; Tsujimoto G; Tsuda K; Ishihara A
Muscle Nerve; 2007 Mar; 35(3):337-43. PubMed ID: 17094100
[TBL] [Abstract][Full Text] [Related]
24. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model.
Patriti A; Facchiano E; Annetti C; Aisa MC; Galli F; Fanelli C; Donini A
Obes Surg; 2005 Oct; 15(9):1258-64. PubMed ID: 16259883
[TBL] [Abstract][Full Text] [Related]
25. Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls.
Sun TH; Heimark DB; Nguygen T; Nadler JL; Larner J
Biochem Biophys Res Commun; 2002 May; 293(3):1092-8. PubMed ID: 12051772
[TBL] [Abstract][Full Text] [Related]
26. Abnormal insulin receptor tyrosine kinase activity in kidney basolateral membranes from non-insulin-dependent diabetic rats.
Grunberger G; Nagy K; Rempinski D; Levy J
J Lab Clin Med; 1990 Jun; 115(6):704-11. PubMed ID: 2164078
[TBL] [Abstract][Full Text] [Related]
27. Caloric restriction modulates insulin receptor signaling in liver and skeletal muscle of rat.
Zhu M; de Cabo R; Anson RM; Ingram DK; Lane MA
Nutrition; 2005 Mar; 21(3):378-88. PubMed ID: 15797682
[TBL] [Abstract][Full Text] [Related]
28. Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats.
Wu Y; Ouyang JP; Wu K; Wang SS; Wen CY; Xia ZY
Br J Pharmacol; 2005 Sep; 146(2):234-43. PubMed ID: 15997237
[TBL] [Abstract][Full Text] [Related]
29. Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.
Meyerovitch J; Backer JM; Kahn CR
J Clin Invest; 1989 Sep; 84(3):976-83. PubMed ID: 2547842
[TBL] [Abstract][Full Text] [Related]
30. Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis.
Avignon A; Yamada K; Zhou X; Spencer B; Cardona O; Saba-Siddique S; Galloway L; Standaert ML; Farese RV
Diabetes; 1996 Oct; 45(10):1396-404. PubMed ID: 8826977
[TBL] [Abstract][Full Text] [Related]
31. Hepatic expression of cytochrome P450 in type 2 diabetic Goto-Kakizaki rats.
Oh SJ; Choi JM; Yun KU; Oh JM; Kwak HC; Oh JG; Lee KS; Kim BH; Heo TH; Kim SK
Chem Biol Interact; 2012 Feb; 195(3):173-9. PubMed ID: 22244987
[TBL] [Abstract][Full Text] [Related]
32. High glucose condition activates protein tyrosine phosphatases and deactivates insulin receptor function in insulin-sensitive rat 1 fibroblasts.
Ide R; Maegawa H; Kikkawa R; Shigeta Y; Kashiwagi A
Biochem Biophys Res Commun; 1994 May; 201(1):71-7. PubMed ID: 8198614
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic properties of VO(dmpp)2 as assessed by in vitro and in vivo studies in type 2 diabetic GK rats.
Domingues N; Pelletier J; Ostenson CG; Castro MM
J Inorg Biochem; 2014 Feb; 131():115-22. PubMed ID: 24333827
[TBL] [Abstract][Full Text] [Related]
34. Hypoglycemic effect and mechanism of a proteoglycan from ganoderma lucidum on streptozotocin-induced type 2 diabetic rats.
Teng BS; Wang CD; Zhang D; Wu JS; Pan D; Pan LF; Yang HJ; Zhou P
Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):166-75. PubMed ID: 22428467
[TBL] [Abstract][Full Text] [Related]
35. Activation of skeletal muscle casein kinase II by insulin is not diminished in subjects with insulin resistance.
Maeda R; Raz I; Zurlo F; Sommercorn J
J Clin Invest; 1991 Mar; 87(3):1017-22. PubMed ID: 1999482
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor-alpha: a continuum of liability between insulin-dependent diabetes mellitus, non-insulin-dependent diabetes mellitus and carcinoma (review).
Holden RJ; Pakula IS; Mooney PA
Med Hypotheses; 1999 Apr; 52(4):319-23. PubMed ID: 10465670
[TBL] [Abstract][Full Text] [Related]
37. Protein tyrosine phosphatase activity in insulin-resistant rodent Psammomys obesus.
Meyerovitch J; Balta Y; Ziv E; Sack J; Shafrir E
Int J Exp Diabetes Res; 2002; 3(3):199-204. PubMed ID: 12458662
[TBL] [Abstract][Full Text] [Related]
38. Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-A(y) mice.
Takada M; Sumi M; Maeda A; Watanabe F; Kamiya T; Ishii T; Nakano M; Akagawa M
Biochem Biophys Res Commun; 2012 Nov; 428(2):315-20. PubMed ID: 23085227
[TBL] [Abstract][Full Text] [Related]
39. Diabetes in the Goto-Kakizaki rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooth muscle cell relaxation.
Sandu OA; Ragolia L; Begum N
Diabetes; 2000 Dec; 49(12):2178-89. PubMed ID: 11118023
[TBL] [Abstract][Full Text] [Related]
40. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling.
Kenner KA; Anyanwu E; Olefsky JM; Kusari J
J Biol Chem; 1996 Aug; 271(33):19810-6. PubMed ID: 8702689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
